HKSE - Delayed Quote HKD

AK MEDICAL (1789.HK)

Compare
4.200
+0.010
+(0.24%)
At close: 4:08:15 PM GMT+8
Loading Chart for 1789.HK
DELL
  • Previous Close 4.190
  • Open 4.190
  • Bid 4.200 x --
  • Ask 4.210 x --
  • Day's Range 4.050 - 4.210
  • 52 Week Range 3.490 - 6.460
  • Volume 4,046,040
  • Avg. Volume 3,629,946
  • Market Cap (intraday) 4.687B
  • Beta (5Y Monthly) -0.76
  • PE Ratio (TTM) 24.71
  • EPS (TTM) 0.170
  • Earnings Date --
  • Forward Dividend & Yield 0.05 (1.07%)
  • Ex-Dividend Date Jun 24, 2024
  • 1y Target Est 6.23

AK Medical Holdings Limited, an investment holding company, designs, develops, produces, and markets orthopedic joint implants and related products in China and internationally. It offers knee, hip, and spinal and trauma replacement implants; and 3D-printed products, such as 3D-printed hip and knee replacement implants, 3D-printed spinal and trauma implants, and customised products and services. The company also distributes third party orthopedic products; and offers surgical instruments and medical irrigators. Its principal customers include distributors, hospitals, physicians and surgeons, and patients. The company was founded in 2003 and is headquartered in Beijing, the People's Republic of China.

www.ak-medical.net

974

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 1789.HK

View More

Performance Overview: 1789.HK

Trailing total returns as of 1/13/2025, which may include dividends or other distributions. Benchmark is

.

YTD Return

1789.HK
13.40%
HANG SENG INDEX
5.82%

1-Year Return

1789.HK
24.64%
HANG SENG INDEX
16.19%

3-Year Return

1789.HK
38.34%
HANG SENG INDEX
22.65%

5-Year Return

1789.HK
58.34%
HANG SENG INDEX
34.09%

Compare To: 1789.HK

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 1789.HK

View More

Valuation Measures

As of 1/10/2025
  • Market Cap

    4.68B

  • Enterprise Value

    3.97B

  • Trailing P/E

    24.68

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    4.01

  • Price/Book (mrq)

    1.77

  • Enterprise Value/Revenue

    3.39

  • Enterprise Value/EBITDA

    15.80

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    17.13%

  • Return on Assets (ttm)

    4.39%

  • Return on Equity (ttm)

    7.81%

  • Revenue (ttm)

    1.1B

  • Net Income Avi to Common (ttm)

    188.78M

  • Diluted EPS (ttm)

    0.170

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    826.16M

  • Total Debt/Equity (mrq)

    3.65%

  • Levered Free Cash Flow (ttm)

    1.79M

Research Analysis: 1789.HK

View More

People Also Watch